Open original FDA record ↗Recall record
- FDA identifier
- Z-0788-2017
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Dec 19, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Medtronic is following up to a May 2013 communication regarding the Priming Bolus function for the SynchroMed Infusion System. Medtronic is updating the Model 8870 software application card (to version AAU01) and the SynchroMed pump labeling to address the priming bolus issue.
Source facts
- Action
- Medtronic Representatives began visiting consignees on 10/3/2016 to replace previous version Model 8870 software application cards, contained within the model 8840 N Vision Clinician Programmer, with the updated version (new version is AAU01). Beginning October 20, 2016, Implanting and Following physicians were sent an Urgent Medical Device Correction letter dated September 2016, . This letter to physicians is informing them of the updated Model 8870 software application card, and changes to SynchroMed infusion system labeling. A response form is requested to be returned to Medtronic. Customers with questions were instructed to contact Medtronic Neuromodulation Technical Services at 1-800-707-0933.
- Initiated
- 2016-10-03
- Root cause
- Under Investigation by firm
- Terminated
- 2022-06-02
- Distribution
- Worldwide Distribution - (US Nationwide) Internationally to Germany, Greece, Australia, United Kingdom, Switzerland, Italy, Norway, France, Canada, and Malta.
- Recall number
- Z-0788-2017
- Recall status
- Terminated
- CDRH record ID
- 150480
- FDA classified
- 2016-12-19
- Recall event number
- 75486